How does propranolol (beta blocker) reduce anxiety in patients with performance or social anxiety disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How Propranolol Reduces Anxiety

Propranolol reduces anxiety by blocking peripheral beta-adrenergic receptors, which prevents adrenaline from causing physical symptoms like rapid heart rate, tremors, and sweating—essentially stopping the body's "fight or flight" response from manifesting physically. 1

Mechanism of Action

Propranolol is a non-selective beta-blocker that works primarily through peripheral blockade of beta-adrenergic receptors, preventing the physical manifestations of sympathetic nervous system activation 1, 2. When you experience anxiety, your body releases adrenaline (epinephrine), which normally binds to beta receptors throughout your body, causing:

  • Increased heart rate and palpitations
  • Trembling and shaking
  • Sweating
  • Nervous tension in muscles 1, 2

By blocking these receptors, propranolol prevents these physical symptoms from occurring, which in turn reduces the overall anxiety experience 2. This is particularly effective because the physical symptoms of anxiety often create a feedback loop—feeling your heart race makes you more anxious, which makes your heart race faster 3.

Central vs. Peripheral Effects

There remains some controversy about whether propranolol works solely through peripheral mechanisms or also has central nervous system effects 2. The fact that beta-blockers that don't cross the blood-brain barrier still show efficacy suggests the peripheral mechanism is primary 2. However, some studies have noted CNS-related side effects like sleep disturbances and nightmares, indicating some central activity 4, 5.

Clinical Effectiveness by Anxiety Type

Performance Anxiety (Where It Works Best)

Propranolol is most effective for situational performance anxiety—like public speaking, test-taking, or stage fright—where physical symptoms are the primary problem 1, 6. The recommended approach is:

  • Dose: 20-40 mg taken 1 hour before the anxiety-provoking event 1, 6
  • Critical caveat: Always advise a trial dose before an important event to assess individual response and tolerability 6
  • This is appropriate for infrequent, isolated performance situations 1

The American College of Surgeons specifically recommends propranolol for surgeons experiencing procedural tremor and anxiety, as it reduces both physiologic tremor and heart rate 1.

Chronic Anxiety Disorders (Where It Does NOT Work Well)

Propranolol is explicitly NOT recommended for chronic anxiety disorders like generalized anxiety disorder or chronic social anxiety disorder 6, 7. The Canadian Clinical Practice Guidelines and international guidelines (2023) specifically deprecate propranolol for chronic social anxiety based on negative evidence 6, 7.

For chronic anxiety, the evidence-based first-line treatments are:

  • SSRIs (escitalopram, sertraline) or SNRIs (venlafaxine) 6, 7
  • Cognitive behavioral therapy (CBT) 1, 6, 7

Panic Disorder

Research does not support propranolol as effective for panic disorder 8. It may provide symptomatic relief for residual somatic complaints like palpitations when combined with other treatments, but should be used cautiously as beta-blockers may induce depression in predisposed patients 8.

Anxiety with Prominent Physical Symptoms

Propranolol may be useful for anxiety disorders characterized by somatic symptoms related to increased adrenergic tone (cardiovascular complaints, tremor), particularly when these are of moderate intensity and recent onset 2, 3. Older studies showed benefit in 80-320 mg daily doses for chronic anxiety with prominent physical symptoms 3, though this approach has largely been superseded by SSRIs/SNRIs.

Absolute Contraindications to Screen For

Before prescribing propranolol, you must exclude 4, 1, 6:

  • Asthma or chronic obstructive pulmonary disease (non-selective beta-blockers increase airway resistance)
  • Bradycardia or heart block (greater than first degree without pacemaker)
  • Heart failure or decompensated systolic heart failure
  • Severe hypotension or cardiogenic shock

Important Cautions

  • Diabetes: Propranolol may mask symptoms of hypoglycemia (tachycardia, sweating), particularly dangerous in type 1 diabetes or insulin-treated patients 4, 1, 6
  • Do not abruptly discontinue after regular use—this can cause rebound symptoms 1, 6
  • Common side effects: Bradycardia, hypotension, fatigue, cold extremities, sleep disturbances, nightmares 4, 1
  • Potential for depression: Use cautiously in patients with depressive illness 8

Clinical Decision Algorithm

For situational/infrequent performance anxiety:

  • Screen for contraindications (asthma, heart block, heart failure, severe hypotension, bradycardia) 6
  • If clear, prescribe propranolol 20-40 mg to take 1 hour before event 1, 6
  • Advise trial dose before important event 6

For frequent performance anxiety or chronic anxiety:

  • First-line: Refer for CBT 1, 6
  • If pharmacotherapy needed: Initiate SSRI/SNRI, not propranolol 6, 7

For anxiety with prominent physical symptoms not responding to benzodiazepines:

  • Consider propranolol as adjunctive therapy 2, 8
  • Typical dose range: 80-320 mg daily in divided doses 3

Why Propranolol Over Other Beta-Blockers

Propranolol is the preferred beta-blocker for anxiety because it is non-selective, has established efficacy for essential tremor (up to 70% of patients), and has the most evidence for performance anxiety 1, 6. Metoprolol is less effective and considered only a second-line alternative for patients with reactive airway disease 1. Atenolol has shown inferior outcomes in cardiovascular trials and has untoward metabolic effects 4.

References

Guideline

Propranolol for Stage Fright

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Propranolol in the treatment of anxiety.

Postgraduate medical journal, 1976

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Propranolol in chronic anxiety disorders. A controlled study.

Archives of general psychiatry, 1980

Guideline

Beta Blocker Recommendation for Anxiety Events

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Propranolol for Anxiety: Efficacy and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Beta-blockers in anxiety disorders.

Journal of affective disorders, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.